tirzepatide safety breastfeeding and breastfeeding: New research offers hope for postpartum moms Are GLP-1 Safe While Breastfeeding?

We look beyond a sole financial remedy

This is category-level context, not a claim about Zevay specifically - this article found no FDA warning letter or state attorney general action naming Zevay, and none should be inferred from what follows: Fall 2025: roughly 80 warning letters to telehealth companies March 2026: 30 more warning letters June 2026: 25 more warning letters All three rounds targeted claims that a compounded product is equivalent to an FDA-approved drug, or that obscure which pharmacy actually compounds the medication

healthcare.gov

10.1172/jci1349

Many patients labeled 'non-responders' actually need higher doses, different injection frequencies, or combination therapynot a medication switch